Delivery Order SPE2DB22D3401-SPE2DB25FT3MP
Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,896.20 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and narcolepsy. The contract, executed on August 13, 2025, with an ultimate completion date of August 14, 2025, operates under a firm fixed price structure with no set-aside designation, indicating competitive award to this qualified pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,963.11 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. This contract, awarded on June 6, 2025, with an ultimate completion date of June 9, 2025, was issued on a firm fixed-price basis without set-aside restrictions, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.29 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on August 15, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,831.88 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on July 8, 2025, with an ultimate completion date of July 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a $4,076.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. No set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,783.60 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on August 25, 2025, with completion expected by August 26, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.38 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order represents a single-transaction procurement under a competitive, non-set-aside arrangement. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,090.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD). This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a direct fulfillment of pharmaceutical supply needs through the federal medical procurement system. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.42 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.40 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). This firm fixed-price delivery order, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a direct purchase under a larger contract vehicle. The award was made through open competition with no set-aside...